Nostos Genomics partners with genetic testing labs to turn data into genomic insights, providing fast and clear diagnoses for people with genetic diseases. Their CE-certified AI-powered platform, AION, automates the interpretation of genetic variants, significantly reducing the time it takes to analyze data and improving the diagnostic success rate. Over 300 million people live with rare genetic diseases, with many enduring long diagnostic journeys. Nostos Genomics aims to accelerate this process with advanced technology that enables labs to diagnose more patients faster.

Nostos Genomics is dedicated to improving the accuracy, speed, and accessibility of genetic testing. They strive to empower patients by delivering the right information at the right time to support informed health decisions. The company's mission is anchored on transparency, kindness, personal responsibility, and making a positive societal impact through innovative genomic medicine solutions.